Mesoblast | MSB - Marktkapitalisierung

Aktienkurs
2.26
Täglich Wechseln
0.08 3.67%
Monatlich
-4.64%
Jährlich
8.13%
Q1 Prognose
2.03




Marktkapitalisierung Veränderung Datum
Avita Medical AUD 105.47M 35.32M 2025-12
Clinuvel Pharmaceuticals AUD 520.28M 83.45M 2025-06
Cochlear AUD 13.02B 4.03B 2026-03
CSL USD 71.32B 15.44B 2026-03
Pacific Edge NZD 194.21M 87.84M 2025-12
Paradigm Biopharmaceuticals AUD 91.31M 27.46M 2026-03
PYC Therapeutics AUD 7.72B 6.76B 2026-03
Ramsay Health Care AUD 9.85B 1.92B 2026-03
Starpharma Holdings AUD 179.24M 28.68M 2026-03
Telix Pharmaceuticals AUD 5.07B 5.81B 2025-12